BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advancing Its Clinical Program, Immunotherapy Seen as Future of Cancer Treatment
Multiple oncology and immunology organizations have identified immunotherapy as the future of cancer treatment BriaCell Therapeutics Corp. is making significant progress in the development of a safe and highly effective immunotherapy solution for advanced breast cancer patients The company is expected to announce new information about the efficacy of its lead product candidate in combination with KEYTRUDA® during the first quarter of 2019 Market forecasts suggest rapid anti-cancer immunotherapy market growth until 2023 For nearly 20 years, researchers have been working on ways to help the immune system better target cancer. New developments in the field are making that possible,…